RG
RMD icon

Rikoon Group’s ResMed RMD Stock Holding History

Rikoon Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$700K Hold
3,610
– – 0.19% 121
2020
Q4 		$767K Buy
3,610
+310
+9% +$61.8K 0.21% 105
2020
Q3 		$566K Buy
3,300
+2,240
+211% +$414K 0.17% 115
2020
Q2 		$204K Buy
+1,060
New +$173K 0.07% 203

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Rikoon Group's RMD Position: Q1 2021 in Review

Rikoon Group held its ResMed (RMD) position steady in Q1 2021 at 3,610 shares worth $700K. The position accounts for 0.19% of the portfolio, ranked #121.

Rikoon Group first reported a position in RMD in Q2 2020 and has held it in 4 quarters since. The position peaked at $767K in Q4 2020. 663 funds tracked by Wall St. Rank hold RMD as of Q1 2021.

  • Rikoon Group held 3,610 shares of ResMed worth $700K as of Q1 2021.
  • Rikoon Group left its ResMed share count unchanged in Q1 2021.
  • ResMed made up 0.19% of Rikoon Group's portfolio in Q1 2021, its #121 holding.
  • Rikoon Group first reported a position in ResMed in Q2 2020 and has held it in 4 quarters since.
  • Rikoon Group's ResMed position peaked at $767K in Q4 2020.
  • 663 funds tracked by Wall St. Rank held ResMed as of Q1 2021.

Based on Rikoon Group's 13F filing for Q1 2021, filed 14 May 2021.